These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 15956118)

  • 1. Therapeutic potential of endothelial progenitor cells in cardiovascular diseases.
    Dzau VJ; Gnecchi M; Pachori AS; Morello F; Melo LG
    Hypertension; 2005 Jul; 46(1):7-18. PubMed ID: 15956118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of progenitor endothelial cells in cardiovascular disease and upcoming therapies.
    Kawamoto A; Asahara T
    Catheter Cardiovasc Interv; 2007 Oct; 70(4):477-84. PubMed ID: 17894361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transplantation of endothelial progenitor cells as therapeutics for cardiovascular diseases.
    Hung HS; Shyu WC; Tsai CH; Hsu SH; Lin SZ
    Cell Transplant; 2009; 18(9):1003-12. PubMed ID: 19650968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Proangiogenic cell-based therapy for treatment of ischemic diseases].
    Silvestre JS
    Med Sci (Paris); 2009 Nov; 25(11):931-8. PubMed ID: 19951667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential use of endothelial progenitor cells for regeneration of the vasculature.
    Yamahara K; Itoh H
    Ther Adv Cardiovasc Dis; 2009 Feb; 3(1):17-27. PubMed ID: 19144668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation and transplantation of autologous circulating endothelial cells into denuded vessels and prosthetic grafts: implications for cell-based vascular therapy.
    Griese DP; Ehsan A; Melo LG; Kong D; Zhang L; Mann MJ; Pratt RE; Mulligan RC; Dzau VJ
    Circulation; 2003 Nov; 108(21):2710-5. PubMed ID: 14597586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stem cells in kidney diseases.
    Soler MJ; José Tomas OP
    J Stem Cells; 2012; 7(4):245-59. PubMed ID: 24196799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD34 hybrid cells promote endothelial colony-forming cell bioactivity and therapeutic potential for ischemic diseases.
    Lee JH; Lee SH; Yoo SY; Asahara T; Kwon SM
    Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1622-34. PubMed ID: 23640491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial progenitor cells as therapeutic vectors in cardiovascular disorders: from experimental models to human trials.
    Ben-Shoshan J; George J
    Pharmacol Ther; 2007 Jul; 115(1):25-36. PubMed ID: 17574679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial progenitor cells as a new agent contributing to vascular repair.
    Miller-Kasprzak E; Jagodziński PP
    Arch Immunol Ther Exp (Warsz); 2007; 55(4):247-59. PubMed ID: 17659378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial and cardiac progenitor cells for cardiovascular repair: A controversial paradigm in cell therapy.
    Bianconi V; Sahebkar A; Kovanen P; Bagaglia F; Ricciuti B; Calabrò P; Patti G; Pirro M
    Pharmacol Ther; 2018 Jan; 181():156-168. PubMed ID: 28827151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of stromal-derived factor-1alpha and vascular endothelial growth factor gene-modified endothelial progenitor cells is more effective for ischemic neovascularization.
    Yu JX; Huang XF; Lv WM; Ye CS; Peng XZ; Zhang H; Xiao LB; Wang SM
    J Vasc Surg; 2009 Sep; 50(3):608-16. PubMed ID: 19595531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial progenitor cells as a therapeutic option in peripheral arterial disease.
    Devanesan AJ; Laughlan KA; Girn HR; Homer-Vanniasinkam S
    Eur J Vasc Endovasc Surg; 2009 Oct; 38(4):475-81. PubMed ID: 19560945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concise review: Circulating endothelial progenitor cells for vascular medicine.
    Asahara T; Kawamoto A; Masuda H
    Stem Cells; 2011 Nov; 29(11):1650-5. PubMed ID: 21948649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular repair by endothelial progenitor cells.
    Zampetaki A; Kirton JP; Xu Q
    Cardiovasc Res; 2008 Jun; 78(3):413-21. PubMed ID: 18349136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Vascular regeneration therapy for intractable vasculitis].
    Kawamoto A; Asahara T
    Nihon Rinsho; 2009 Mar; 67(3):612-8. PubMed ID: 19280941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coadministration of endothelial and smooth muscle progenitor cells enhances the efficiency of proangiogenic cell-based therapy.
    Foubert P; Matrone G; Souttou B; Leré-Déan C; Barateau V; Plouët J; Le Ricousse-Roussanne S; Lévy BI; Silvestre JS; Tobelem G
    Circ Res; 2008 Sep; 103(7):751-60. PubMed ID: 18723447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How to utilize Ca²⁺ signals to rejuvenate the repairative phenotype of senescent endothelial progenitor cells in elderly patients affected by cardiovascular diseases: a useful therapeutic support of surgical approach?
    Moccia F; Dragoni S; Cinelli M; Montagnani S; Amato B; Rosti V; Guerra G; Tanzi F
    BMC Surg; 2013; 13 Suppl 2(Suppl 2):S46. PubMed ID: 24267290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial progenitor cells: a novel tool for the therapy of ischemic diseases.
    Alev C; Ii M; Asahara T
    Antioxid Redox Signal; 2011 Aug; 15(4):949-65. PubMed ID: 21254837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial progenitor cells: new perspectives and applications in cardiovascular therapies.
    Marsboom G; Janssens S
    Expert Rev Cardiovasc Ther; 2008 Jun; 6(5):687-701. PubMed ID: 18510485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.